網宿科技(300017.SZ):目前研發及技術服務人員的佔比超60%,2022年研發投入4.62億元
格隆匯5月6日丨網宿科技(300017.SZ)於2023年5月5日下午15:00-17:00召開業績説明會,在問答環節中,就“公司今年是否有加大投入研發的計劃,目前研發團隊實力如何?”,公司回覆稱,目前,公司研發及技術服務人員佔員工總數比例超過60%。2022年,公司研發投入4.62億元,堅持對邊緣計算、安全及基礎技術研究做持續性的投入,提升公司技術競爭力。未來,公司將持續保持較大的研發投入,不斷夯實公司的核心競爭力,拓寬公司的技術護城河。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.